Chronic News and Research

RSS

Positive data from Lexicon LX1032 Phase 2 study on carcinoid syndrome

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced positive, top-line proof-of-concept data from its recently completed Phase 2 study in carcinoid syndrome with LX1032, telotristat etiprate. Carcinoid syndrome is a chronic condition caused by neuroendocrine tumors that usually originate from the gastrointestinal tract.

9 Aug 2011

Novel link between two receptors mediates fungal recognition in macrophages

Whitehead Institute researchers have uncovered a novel association between two fungal recognition receptors on the surface of certain immune cells, called macrophages.

9 Aug 2011

U-M saves more than $22M during Medicare Physician Group Practice Demonstration Project

Medicare patients received better care at the University of Michigan Health System, and U-M staff have saved more than $22 million on the cost of that care during a five-year demonstration project.

9 Aug 2011

Study helps clarify definition of gastroesophageal reflux disease

Modifying stomach acid levels may not be enough to treat symptoms in neonates suspected of having gastroesophageal reflux disease. According to a study from Nationwide Children's Hospital, this is the first study to classify reflux and its associated symptoms in neonates based on how and what is refluxed.

9 Aug 2011

Continuous positive airway pressure machine more effective for sleep apnea patients

Among the treatments for obstructive sleep apnea, the effectiveness of a nighttime-breathing machine called a "CPAP" was backed by the strongest evidence, and a mouthpiece worn at night was also shown to be effective, according to a new report funded by HHS' Agency for Healthcare Research and Quality.

9 Aug 2011

HUYA enters strategic partnership with King's Lab

HUYA Bioscience International, a leader in globalizing China's biopharmaceutical innovations, today announced a strategic partnership with the Shanghai Jiao Tong University School of Pharmacy King's Lab. The alliance with HUYA will assist King's Lab in accelerating the development of their novel drugs to international standards.

8 Aug 2011

House call program improves quality of care for Vets in Philadelphia

Dr. Bruce Kinosian still makes house calls, and he's proud of it. In fact, he introduces himself as a physician who goes to see his patients in their homes rather than insisting that they come to see him at his office.

8 Aug 2011

Inhibitex second quarter net loss decreases to $5.3 million

Inhibitex, Inc. today announced its financial results for the second quarter ended June 30, 2011 and provided an update on several recent clinical and corporate developments.

8 Aug 2011

FDA approves Relievant IDE for Intracept System to treat chronic low back pain

Relievant Medsystems, Inc. today announced the company has received Food and Drug Administration approval of an Investigational Device Exemption to begin their SMART pivotal trial to evaluate the safety and effectiveness of the Intracept System for treatment of chronic low back pain.

8 Aug 2011

Fallout from S&P downgrade could add heightened 'super committee' focus on entitlement cuts

Speculation continues about whether the yet-to-be named panel, created by the debt deal, will be able to find the necessary budget cuts to reach the goal of $1.2 trillion in savings over the next 10 years. House Budget Committee Chairman Paul Ryan, R-Wis., is among those who have low expectations.

8 Aug 2011

Unigene second quarter revenue decreases to $2.5 million

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced second quarter financial results for the period ended June 30, 2011. The Company highlighted significant progress achieved in the second quarter with the continued execution of its turnaround strategy.

8 Aug 2011

First Edition: August 8, 2011

Kaiser Health News staff writer Marilyn Werber Serafini reports: "GOP presidential hopeful Tim Pawlenty has scorned the health plans engineered by President Barack Obama and former Massachusetts Gov. Mitt Romney, even linking them with the term Obamneycare. Instead, the former Minnesota governor is brandishing a health plan his state passed in 2008 as a model for the nation".

8 Aug 2011

Idera second quarter net loss increases to $6.3 million

Idera Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2011. Idera is a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-Like receptors (TLRs).

5 Aug 2011

Health Affairs report describes ground-breaking effort that aims to prevent opioid abuse

Fatal overdoses involving prescribed opioids tripled in the United States between 1999 and 2006, climbing to almost 14,000 deaths annually-more than cocaine and heroin overdoses combined. Hospitalizations and emergency room visits related to prescription opioid pain medicines such as oxycodone and hydrocodone also increased dramatically in the same period.

5 Aug 2011

Washington Post publishes leadership roundtable opinion pieces on foreign aid and Somalia

"Amid budget crisis, a defense of foreign aid," Sen. John Kerry: "On one point we must remain resolute: This is not time for America to pull back from the world. This is a time to step forward".

5 Aug 2011

Study sheds new light on how surgery impacts chronic kidney disease, bone health

Researchers at the University of California, San Diego School of Medicine have shed new light on how surgery impacts both chronic kidney disease and bone health, particularly in women.

5 Aug 2011

New legislation allows physicians in Texas to treat chronic Lyme disease

Summertime, when kids and grown-ups abandon the confines of the indoors and head outside to camp, hike, fish and commune with nature -- and all of her friends. Flies, mosquitoes and ticks are just a few of the critters that go along with summer outdoors, and we all do our best to avoid the biting and stinging insects, but what happens if you are accosted by a tick? What are the myths behind Lyme disease and other tick-borne diseases in Texas?.

5 Aug 2011

Speculation about essential benefits package takes spotlight

As the Department of Health and Human Services works toward setting the specifics of an essential health benefits package — the minimum coverage that would be offered by plans participating in the exchanges — stakeholders are offering actuarial models and suggestions of what they think would be the best approach.

5 Aug 2011

Virginia Tech student receives prestigious award for cellular signaling receptor study linked to diabetes, obesity

Stephanie Nicole "Nikki" Lewis, a graduate student in the interdisciplinary doctoral program in genetics, bioinformatics, and computational biology at Virginia Tech, has been awarded the prestigious Ruth L. Kirschstein National Research Service Award for Predoctoral Research through the National Institutes of Health for her study of a cellular signaling receptor that is associated with chronic inflammatory diseases such as diabetes, obesity, and inflammatory bowel disease.

5 Aug 2011

U.S. PTO to reissue two patents for Dey Pharma's Perforomist Inhalation Solution

Dey Pharma L.P., a subsidiary of Mylan Inc., today announced that the U.S. Patent and Trademark Office intends to reissue both of the patents related to Perforomist Inhalation Solution 20 mcg/2mL vial that had been placed into reexamination by Sepracor, now known as Sunovion Pharmaceuticals.

4 Aug 2011

Chronic News and Research

Positive data from Lexicon LX1032 Phase 2 study on carcinoid syndrome

Novel link between two receptors mediates fungal recognition in macrophages

U-M saves more than $22M during Medicare Physician Group Practice Demonstration Project

Study helps clarify definition of gastroesophageal reflux disease

Continuous positive airway pressure machine more effective for sleep apnea patients

HUYA enters strategic partnership with King's Lab

House call program improves quality of care for Vets in Philadelphia

Inhibitex second quarter net loss decreases to $5.3 million

FDA approves Relievant IDE for Intracept System to treat chronic low back pain

Fallout from S&P downgrade could add heightened 'super committee' focus on entitlement cuts

Unigene second quarter revenue decreases to $2.5 million

First Edition: August 8, 2011

Idera second quarter net loss increases to $6.3 million

Health Affairs report describes ground-breaking effort that aims to prevent opioid abuse

Washington Post publishes leadership roundtable opinion pieces on foreign aid and Somalia

Study sheds new light on how surgery impacts chronic kidney disease, bone health

New legislation allows physicians in Texas to treat chronic Lyme disease

Speculation about essential benefits package takes spotlight

Virginia Tech student receives prestigious award for cellular signaling receptor study linked to diabetes, obesity

U.S. PTO to reissue two patents for Dey Pharma's Perforomist Inhalation Solution

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News